Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 47
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Pharm Dev Technol ; 24(7): 883-890, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31164031

RESUMEN

Pioglitazone (PGZ) is an antidiabetic agent belongs to thiazolidinediones. Binary systems of PGZ in the matrices of kollicoat IR (KL) and gelucire (GL) at different weight ratios were prepared by kneading and co-evaporation methods, respectively. The drug solid dispersions were characterized in terms of in vitro dissolution studies, differential scanning calorimetry (DSC), and X-ray powder diffraction (XRPD). The effects of PGZ-KL (1:4) solid dispersion on the body weight, blood glucose, renal and hepatic functions of the diabetic rats were evaluated. Enhanced drug dissolution was observed in the case of PGZ-KL binary systems depending on the drug to polymer weight ratio. A reduction of 39.7, 32.7 and 26.6% for diabetic control, PGZ untreated and PGZ-KL (1:4), respectively, was recorded after 2 weeks. PGZ-KL (1:4) solid dispersion also showed significantly lower glucose blood level (p < 0.05) compared to the diabetic control group along the period of experiment. The level of ALT was highly significantly decreased in the animal group treated with PGZ-KL solid dispersion (p < 0.001). However, treatment of diabetic rats with either PGZ-KL or PGZ untreated significantly reduced the level of creatinine compared to the diabetic control and the difference between them was non-significant.


Asunto(s)
Portadores de Fármacos/química , Hipoglucemiantes/administración & dosificación , Pioglitazona/administración & dosificación , Polivinilos/química , Triglicéridos/química , Animales , Diabetes Mellitus Experimental/tratamiento farmacológico , Liberación de Fármacos , Interacciones Hidrofóbicas e Hidrofílicas , Hipoglucemiantes/química , Hipoglucemiantes/uso terapéutico , Masculino , Pioglitazona/química , Pioglitazona/uso terapéutico , Ratas Wistar , Solubilidad , Comprimidos
2.
J Cell Biochem ; 119(5): 3903-3912, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-29165830

RESUMEN

Several studies have reported that metformin is cardioprotective for diabetic and non-diabetic ischemic hearts through mechanisms that cannot be entirely attributed to its anti-hyperglycemic effect. This study was designed to investigate the cardioprotective effects of metformin with and without vitamin E after induction myocardial infarction (MI) in rats, using isoproterenol. Administration of metformin or vitamin E significantly reduced the cardiac mass index (P < 0.01), ameliorated the changes to cardiac biomarkers, and attenuated oxidative stress levels compared to the isoproterenol group. Interestingly, combination therapy showed a slight synergistic effect. Histopathological analysis suggested that metformin treatment reduced NF-κB expression and protected against isoproterenol-induced MI. Our results indicate that metformin mediates a cardioprotective effect against isoproterenol-induced MI via antioxidant activity and modulation of the NF-κB signaling pathway. This suggests that metformin would be beneficial in MI treatment.


Asunto(s)
Lesiones Cardíacas/inducido químicamente , Lesiones Cardíacas/prevención & control , Isoproterenol/efectos adversos , Metformina/farmacología , Transducción de Señal/efectos de los fármacos , Vitamina E/farmacología , Animales , Lesiones Cardíacas/metabolismo , Lesiones Cardíacas/patología , Isoproterenol/farmacología , Masculino , FN-kappa B/metabolismo , Ratas , Ratas Wistar
3.
Saudi Pharm J ; 26(2): 217-223, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30166919

RESUMEN

The underlying pathology of cardiac damage involves various molecular and signaling pathways. Therefore, this study aimed to explore the role of Quercetin (Querc), alone or in combination with Melatonin (Melat) against cardiac damage induced by sodium nitrite (Sod nit), as well as to elucidate different signaling pathways. Querc and Melat were injected intraperitoneally (i.p.), followed by induction of hypoxia in rats by using a single dose of Sod nit (60 mg/kg, s.c.). Treatment with Sod nit significantly decreased hemoglobin (Hb) levels in blood. Pretreatment of hypoxic rats with Querc and/or Melat elevated the declined Hb concentration. The forementioned antioxidants also successfully ameliorated the alteration of heat shock protein 70 (HSP-70) and markers of cardiac injury, including troponin T (Trop. T), creatine kinase-MB (CK-MB), tumor necrosis factor-α (TNF α), and C-reactive protein (CRP) in the rats serum. Furthermore, RT-PCR revealed that these antioxidants successfully modulated mRNA expression of NF-κB, Bax, Bcl-2, and flt-1. They also regulated vascular endothelial growth factor (VEGF), the apoptosis marker caspase 3, and oxidative DNA damage in cardiac tissue, compared to Sod nit-intoxicated rats. The present biochemical results are reinforced by histopathological examination. IN CONCLUSION: The results reflected that treatment with Querc in combination with Melat was most effective in improving Sod nit-toxicity induced cardiac damage, thus confirming the promising role of this combination as an effective treatment for cardiac damage induced by other cardio-toxic agents.

4.
J Biochem Mol Toxicol ; 31(12)2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28833918

RESUMEN

This study aimed to explore the efficiency of carnosine (Cs) and/or l-arginine (Agn) in the downregulation of apoptotic and inflammatory molecule expression and DNA damage caused hepatic injury in response to sodium nitrite (Sd)-induced hypoxia in rats. Rats were injected with Sd; Agn or/and Cs were administrated prior to Sd intoxication. Sd significantly decreased hemoglobin concentration and Bcl-2 mRNA expression, while increased expressions of apoptotic markers (Bax and caspase), tumor necrosis factor-α, nuclear factor kappa B, and C-reactive protein and the oxidative DNA damage in hepatic tissue. Moreover, administration of Agn or/and Cs exhibited a modulation of the previous parameters. However, concurrent treatment with the forementioned antioxidants modulated these levels. It was concluded that the treatment with the combination of Agn and Cs was the most effective regimen in ameliorating Sd toxicity accompanied by hypoxic stress.


Asunto(s)
Antioxidantes/farmacología , Arginina/farmacología , Carnosina/farmacología , Daño del ADN , Expresión Génica/efectos de los fármacos , Alanina Transaminasa/sangre , Animales , Proteínas Reguladoras de la Apoptosis/metabolismo , Proteína C-Reactiva/metabolismo , Caspasa 3/metabolismo , Hipoxia de la Célula , Evaluación Preclínica de Medicamentos , Hemoglobinas/metabolismo , Masculino , Estrés Oxidativo/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas Wistar , Factor de Necrosis Tumoral alfa/sangre
5.
J Biochem Mol Toxicol ; 31(5)2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28000380

RESUMEN

The objective of this work is to study the protective effects of Quercetin against sodium nitrite-induced hypoxia on liver, lung, kidney and cardiac tissues, also to explore novel mechanism of this compound. Male albino rats were injected with sodium nitrite (75 mg/kg). Quercetin (200 mg kg-1 ,- i.p.) was administrated 24 and 1 h respectively prior to sodium nitrite intoxication, hypoxia significantly decreased hemoglobin concentration, while increased expressions of HIF, Bax, Smad-2, TGF-ß, and AKT. However, administration of Quercetin played a modulatory role against the previous mentioned apoptotic factors protein expressions in all the studied tissues. On the other hand, Bcl-2 was downregulated by NaNO2 , whereas concurrent treatment with Quercetin increased its expression. It was concluded that Quercetin possesses an anti-apoptotic action induced by NaNO2 -intoxication via different mechanisms. Quercetin administration is recommended in areas of high altitudes to combat the hazard effect of hypoxia in different organs and in some diseases accompanied by hypoxic stress.


Asunto(s)
Apoptosis/efectos de los fármacos , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Quercetina/farmacología , Proteína Smad2/metabolismo , Nitrito de Sodio/toxicidad , Factor de Crecimiento Transformador beta/metabolismo , Proteína X Asociada a bcl-2/metabolismo , Animales , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Inflamación/patología , Masculino , Especificidad de Órganos/efectos de los fármacos , Ratas , Ratas Wistar
6.
Anim Biotechnol ; 28(4): 253-259, 2017 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-28103144

RESUMEN

Overexpression of nuclear factor (NF-κB) or activation of Smad3 by transforming growth factor ß (TGF-ß1) induced by oncogenes results in overexpression of fibrotic processes and hence cell death. The objective of this study is to examine whether Silymarin (Sil) alone or in combination with Vitamin E (Vit E) and/or Curcumin (Cur) plays a modulatory role against the overexpression of NF-κB, and TGF-ß that induced in response to carbon tetrachloride (CCl4) administration. The present work revealed that CCl4 induced elevation of in serum alanine aminotransferase (ALT), Apoptosis regulator (Bax), Smad3, TGF-ß, and NF-kB hepatic mRNA expression (using Real-time PCR), administration of Sil alone downregulated these expressions. Treatment with Vit E acid and/ or Cur along with Sil produced best results in this concern. B-cell lymphoma 2 (Bcl-2) expressions were downregulated by CCl4; whereas concurrent treatment of Vit E and/or Cur along with Sil increased its expression. On conclusion, the use of Vit E and/or Cur could potentiate the antiapoptotic action of Sil.


Asunto(s)
Antioxidantes/farmacología , Proteínas Reguladoras de la Apoptosis/metabolismo , Apoptosis/efectos de los fármacos , Tetracloruro de Carbono/toxicidad , Regulación de la Expresión Génica/efectos de los fármacos , Hígado/efectos de los fármacos , Alanina Transaminasa/sangre , Animales , Proteínas Reguladoras de la Apoptosis/genética , Curcumina/farmacología , Hígado/metabolismo , Masculino , FN-kappa B/genética , FN-kappa B/metabolismo , Ratas , Reacción en Cadena en Tiempo Real de la Polimerasa , Silimarina/farmacología , Proteína smad3/genética , Proteína smad3/metabolismo , Factor de Crecimiento Transformador beta/genética , Factor de Crecimiento Transformador beta/metabolismo , Vitamina E/farmacología
7.
BMC Complement Altern Med ; 16(1): 414, 2016 Oct 24.
Artículo en Inglés | MEDLINE | ID: mdl-27776513

RESUMEN

BACKGROUND: Hepatic fibrosis and its end point; cirrhosis, are the major cause of liver failure and death in patients with chronic liver disease. Therefore, the need for an effective treatment is evident. This study was designed to assess the potential effects of aqueous extract of date fruits, either flesh (DFE) or pits (DPE), on oxidative DNA damage and liver inflammation induced by carbon tetrachloride (CCl4) and whether they are related to inhibition of nuclear factor-κB pathway. In addition, the fibrolytic potential was evaluated via measuring matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases -1 and -2. METHODS: Rats were divided into the following groups: normal control, model control (CCl4 only), CCl4 + DFE, CCl4 + DPE and CCl4 + coffee. Coffee was used as a positive control. Fibrosis was induced by chronic administration of CCl4 (0.4 ml/kg) 3× a week for 8 weeks, and rats were treated with 6 ml/kg/day of DFE or DPE for 8 weeks. Liver homogenate was prepared for evaluation of oxidative stress, DNA damage, inflammatory and fibrolytic markers. Data are analyzed using one-way analysis of variance followed by a Tukey-Kramer post hoc test. RESULTS: Both DFE and DPE significantly attenuated CCl4-induced oxidative damage as indicated by reducing lipid, protein and DNA oxidation in addition to increasing the levels of hepatic catalase activity. Both extracts blocked the accumulation of collagen I in the liver and ameliorated the increased expression of collagen III and α-smooth muscle actin suggesting suppression of profibrotic response induced by CCl4. DFE and DPE also upregulated the expression of heme oxygenase-1 and attenuated the nuclear factor-κB activation and cycloxygenase-2 expression reflecting their anti-inflammatory potential. Additionally, both flesh and pits extracts attenuated the increase in the tissue inhibitor of metalloproteinases -1 and -2 suggesting their fibrolytic activity. CONCLUSION: Our data suggest that DFE or DPE can prevent liver fibrosis by suppressing genotoxicity and nuclear factor-κB inflammatory pathway and by promoting collagen degradation.


Asunto(s)
Daño del ADN/efectos de los fármacos , Cirrosis Hepática , Hígado/efectos de los fármacos , FN-kappa B/metabolismo , Phoeniceae/química , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , Animales , Tetracloruro de Carbono/toxicidad , Ciclooxigenasa 2/metabolismo , Frutas/química , Hemo-Oxigenasa 1/metabolismo , Hígado/patología , Cirrosis Hepática/inducido químicamente , Cirrosis Hepática/metabolismo , Masculino , Extractos Vegetales/química , Sustancias Protectoras/química , Ratas , Ratas Wistar , Inhibidores Tisulares de Metaloproteinasas/metabolismo
8.
Toxicol Mech Methods ; 26(1): 1-10, 2016 01.
Artículo en Inglés | MEDLINE | ID: mdl-26275125

RESUMEN

CONTEXT: Traumatic brain injury in the pediatric population can have a great economic and emotional impact on both the child's family and society. OBJECTIVE: The present study aimed to compare the effects of carnosine (CAR) and/or cyclosporine A (CyA) on oxidative brain damage after closed head injury (CHI) in immature rats. MATERIALS AND METHODS: Thirty-day-old rat pups were divided into five groups: non-traumatic control group, trauma group underwent CHI, trauma group injected with CAR (200 mg/kg, i.p.) following CHI for 7 d, trauma group injected with CyA (20 mg/kg, i.p.) given 15 min and 24 h after CHI, and trauma group treated with CAR and CyA. At the end of the treatment, rats were sacrificed; blood and brains were collected for assessing different biochemical parameters. RESULTS: Trauma significantly increased brain level of malondialdehyde, nitric oxide, glucose, calcium, inflammatory mediators. Brain DNA damage was confirmed by comet assay and the significant increase in brain caspase-3 activity. Moreover, the serum level of Fas ligand in traumatized animals was significantly elevated. Concomitant decrease in brain-reduced glutathione (GSH) and calcium-adenosine triphosphatase activity was observed in the traumatized-untreated group. Treatment of traumatized animals with CAR and/or CyA ameliorated all the biochemical changes induced by CHI with marked protective effect in the combination group. DISCUSSION AND CONCLUSION: CAR and CyA exerted a synergistic neuroprotective effect against CHI through blocking the induction of lipid peroxidation, reducing inflammatory, and oxidative stress biomarkers, preserving brain GSH content, and reducing the alterations in brain apoptotic biomarkers in traumatized animals.


Asunto(s)
Apoptosis/efectos de los fármacos , Carnosina/uso terapéutico , Ciclosporina/uso terapéutico , Traumatismos Cerrados de la Cabeza/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Animales , Apoptosis/inmunología , Biomarcadores/análisis , Encéfalo/efectos de los fármacos , Encéfalo/crecimiento & desarrollo , Encéfalo/inmunología , Encéfalo/metabolismo , Carnosina/administración & dosificación , Ciclosporina/administración & dosificación , Citocinas/inmunología , Sinergismo Farmacológico , Quimioterapia Combinada , Traumatismos Cerrados de la Cabeza/inmunología , Traumatismos Cerrados de la Cabeza/metabolismo , Traumatismos Cerrados de la Cabeza/patología , Masculino , Fármacos Neuroprotectores/administración & dosificación , Estrés Oxidativo/inmunología , Ratas Wistar
9.
Toxicol Mech Methods ; 26(4): 243-50, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27043868

RESUMEN

Transforming growth factor-ß (TGF-ß1) enhances the expression of apoptosis induced by certain cytokines and oncogenes. Activation of small mother against decapentaplegic (Smads) by TGF-ß results in fibrotic, apoptotic processes. PI-3/AKT focal adhesion kinase-phosphatidylinositol3-kinase (AKT), the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription-3 (STAT3) pathways are influence in COX-2 and VEGF-stimulating pathways. NF-E2-related factor-2 (Nrf2) is an essential transcription factor that regulates an array of detoxifying and antioxidant defense genes expression in the liver. The objective of this study is to examine whether silymarin alone or in combination with vitamin E and/or curcumin plays a modulatory role against MAPK, STAT3, AKT, Smad-2 and TGF-ß protein expressions that produced apoptotic damage in rat's liver by the administration of carbon tetrachloride (CCl4). The results of the present work revealed that CCl4-induced an elevation of serum alanine aminotransferase (ALT) with concomitant increase in MAPK, STAT3, AKT, Smad-2 and TGF-ß hepatic protein expression, administration of silymarin alone down regulates these expressions. Treatment with vitamin E and/or curcumin along with silymarin produced best results in this concern. On the other hand, Nrf2 protein expression was down regulated by CCl4 whereas concurrent treatment with vitamin E and/or curcumin along with silymarin increased this expression. It was concluded that CCl4-induced protein expression of apoptotic and fibenorgenic factors. Whereas administration of silymarin alone or in combination with vitamin E and/or curcumin plays a modulatory role against the previous aforementioned apoptotic factors expressions. The use of vitamin E and/or curcumin potentiates the anti-apoptotic action of silymarin. So this combination can be used as hepatoprotective agent against other hepatotoxic substances.


Asunto(s)
Antioxidantes/uso terapéutico , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Curcumina/uso terapéutico , Cirrosis Hepática Experimental/prevención & control , Silimarina/uso terapéutico , Vitamina E/uso terapéutico , Animales , Antioxidantes/administración & dosificación , Tetracloruro de Carbono/toxicidad , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/complicaciones , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Curcumina/administración & dosificación , Quimioterapia Combinada , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Cirrosis Hepática Experimental/sangre , Cirrosis Hepática Experimental/etiología , Cirrosis Hepática Experimental/metabolismo , Pruebas de Función Hepática , Masculino , Ratas Sprague-Dawley , Silimarina/administración & dosificación , Vitamina E/administración & dosificación
10.
Pharmacology ; 95(5-6): 229-39, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25967095

RESUMEN

This study was conducted to investigate whether the renoprotective effects of fenofibrate are mediated via attenuation of endothelial dysfunction and modulating the mRNA expression of adenosine monophosphate-activated protein kinase (AMPK) and its downstream kinase liver kinase B1 (LKB1) in rats with diabetic nephropathy (DN). Diabetes was induced by a single intraperitoneal injection of streptozotocin (55 mg kg(-1)). Fenofibrate (100 mg kg(-1), p.o.) was given to diabetic rats daily for 12 weeks. Treatment with fenofibrate significantly improved the renal function as revealed by the significant reductions in urinary albumin excretion and serum levels of creatinine and urea, in addition to the significant increase in creatinine clearance compared with the diabetic control group. Hyperglycemia-induced oxidative damage was ameliorated by treatment with fenofibrate as indicated by the significantly increased levels of glutathione and catalase together with the significant decrease in lipid peroxidation. Administration of fenofibrate caused significant increases in renal nitric oxide (NO) production and mRNA expression of endothelial NO synthase (eNOS), AMPK and LKB1, reflecting improvement of endothelial function. Our results give further insights into the mechanisms underlying the protective role of fenofibrate in DN via modulation of AMPK, LKB1 and eNOS mRNA expression.


Asunto(s)
Proteínas Quinasas Activadas por AMP/genética , Nefropatías Diabéticas/metabolismo , Fenofibrato/farmacología , Hipolipemiantes/farmacología , Sustancias Protectoras/farmacología , Proteínas Serina-Treonina Quinasas/genética , Quinasas de la Proteína-Quinasa Activada por el AMP , Animales , Glucemia/análisis , Nefropatías Diabéticas/tratamiento farmacológico , Nefropatías Diabéticas/patología , Fenofibrato/uso terapéutico , Hipolipemiantes/uso terapéutico , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Metabolismo de los Lípidos/efectos de los fármacos , Masculino , Óxido Nítrico Sintasa de Tipo III/genética , Nitritos/metabolismo , Sustancias Protectoras/uso terapéutico , ARN Mensajero/metabolismo , Ratas Wistar
11.
Pak J Pharm Sci ; 28(2): 499-508, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25730804

RESUMEN

Cardiovascular complications have become a major cause of mortality for diabetic patients. Glibenclamide is an effective hypoglycemic agent, but failed to alleviate diabetic complications. This study aimed to evaluate whether the addition of zinc to glibenclamide could mitigate such complications. Diabetes was induced using streptozotocin (60 mg/kg, i.p.). Cardiovascular complications were detected by the significant rise of cardiac enzymes, serum lipids, myocardial oxidative stress and cardiac levels of tumor necrosis factor-α (TNF-α, a marker for inflammation) as well as massive histological changes in the heart wall in diabetic control compared to non-diabetic group. Levels of serum nitric oxide and cardiac vascular endothelial growth factor (VEGF, an angiogenic marker) were lower in diabetic rats. Addition of zinc sulfate (30mg/kg) to glibenclamide (600ßg/kg) resulted in significant improvement in cardiac biomarkers, oxidative status and serum lipids. Highly significant reduction in cardiac TNF-α (P<0.001), in addition to significant rise in nitric oxide (P< 0.05) and VEGF (P<0.01) were observed. Cellular infiltration and myocardial edema were ameliorated. These results suggest that a combined treatment of zinc and glibenclamide might be a potential therapy for preventing the risk of cardiovascular complications and reducing the mortality rate among diabetic patients.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Complicaciones de la Diabetes/prevención & control , Diabetes Mellitus Experimental/tratamiento farmacológico , Gliburida/administración & dosificación , Hipoglucemiantes/administración & dosificación , Sulfato de Zinc/administración & dosificación , Animales , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/complicaciones , Lípidos/sangre , Masculino , Óxido Nítrico/biosíntesis , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Estreptozocina , Factor A de Crecimiento Endotelial Vascular/análisis
12.
J Pharm Pharm Sci ; 16(5): 848-67, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24393559

RESUMEN

PURPOSE: Accumulating evidences suggest a critical role of trace metal dyshemostasis in oxidative stress and cardiac dysfunction after myocardial infarction (MI). This study investigated the cardioprotective effects of selenium yeast (Se), chromium picolinate Cr(pic)3, zinc sulfate (Zn) and their combination on isoproterenol (ISO)-induced MI. METHODS: Rats were divided into six groups: normal control, ISO control, Se-pretreated (0.1 mg/kg), Cr(pic)3-pretreated (400 µg/kg), Zn-pretreated (30 mg/kg) and metal combination-pretreated groups. All metals were administered for 28 days and at the 27th day, MI was induced by subcutaneous injection of ISO (85 mg/kg) once for two consecutive days. RESULTS: ISO control group showed hyperlipidemia, elevation of cardiac biomarkers and lipid peroxidation and increased immunostaining of p47 phox NADPH oxidase subunit in addition to decreased levels of glutathione (GSH), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx). Cardiac levels of tumor necrosis factor-α (TNF-α) were increased, while vascular endothelial growth factor (VEGF, the major angiogenic factor) was decreased. Pretreatment with Se normalized the cardiac enzymes, lipid peroxidation, GSH, SOD, CAT, GPx, TNF-α and VEGF (P<0.001) and reduced the immunostaining of p47 phox subunit. However, Se failed to correct the dyslipidemia. Cr(pic)3 significantly improved lipid profile (P<0.001) and all other biochemical deviations except for VEGF. Zn, but to lesser extent, reduced the oxidative damage and TNF-α levels and improved both dyslipidemia and angiogenesis. Combination therapy exhibited less prominent protection compared to individual metals. CONCLUSION: Daily supplementation with trace metals is promising for improving myocardial performance via preventing oxidative damage, induction of angiogenesis, anti-inflammatory and/or anti-hyperlipidemic mechanisms.


Asunto(s)
Cardiotónicos/uso terapéutico , Infarto del Miocardio/tratamiento farmacológico , Ácidos Picolínicos/uso terapéutico , Selenio/uso terapéutico , Sulfato de Zinc/uso terapéutico , Animales , Aterosclerosis/prevención & control , Cardiotónicos/sangre , Cardiotónicos/farmacocinética , Quimioterapia Combinada , Dislipidemias/tratamiento farmacológico , Dislipidemias/metabolismo , Dislipidemias/patología , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Inflamación/patología , Isoproterenol , Masculino , Infarto del Miocardio/inducido químicamente , Infarto del Miocardio/metabolismo , Infarto del Miocardio/patología , Miocardio/metabolismo , Miocardio/patología , NADPH Oxidasas/metabolismo , Neovascularización Fisiológica/fisiología , Estrés Oxidativo/efectos de los fármacos , Ácidos Picolínicos/sangre , Ácidos Picolínicos/farmacocinética , Ratas , Ratas Wistar , Saccharomyces cerevisiae , Selenio/sangre , Selenio/farmacocinética , Sulfato de Zinc/sangre , Sulfato de Zinc/farmacocinética
13.
Behav Pharmacol ; 23(2): 153-61, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22411174

RESUMEN

Diabetic neuropathy is the most common chronic complication of diabetes. The aim of the present study was to evaluate the protective effects of curcumin against neuropathy in gliclazide-treated diabetic rats. Diabetes was induced by an intraperitoneal injection of streptozotocin (45 mg/kg). Diabetic animals were given gliclazide (10 mg/kg, orally) alone or combined with curcumin (100 mg/kg, orally) or gabapentin (30 mg/kg, intraperitoneally as a positive control). Behavioral responses to thermal (hot plate and tail flick) and mechanical (tail pinch) pain, and some biochemical tests (serum glucose, C-peptide, peroxynitrite, lipid peroxides, and tumor necrosis factor-α) were assessed after 5 consecutive weeks of daily treatment. Combined treatment of curcumin with gliclazide significantly increased hot-plate and tail-flick latencies in comparison with that of the diabetic control group. The threshold of mechanical hyperalgesia was also significantly elevated. Serum glucose and C-peptide levels were significantly increased in the combined treatment compared with the diabetic control group, whereas serum levels of peroxynitrite, lipid peroxide, and tumor necrosis factor-α production were significantly decreased. The data suggest that the combination of curcumin with gliclazide may protect against the development of diabetic neuropathy, with favorable effects with respect to the gliclazide/gabapentin combination.


Asunto(s)
Aminas/uso terapéutico , Curcumina/uso terapéutico , Ácidos Ciclohexanocarboxílicos/uso terapéutico , Diabetes Mellitus Experimental/tratamiento farmacológico , Neuropatías Diabéticas/prevención & control , Gliclazida/uso terapéutico , Ácido gamma-Aminobutírico/uso terapéutico , Aminas/administración & dosificación , Aminas/farmacología , Analgésicos/administración & dosificación , Analgésicos/farmacología , Analgésicos/uso terapéutico , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/farmacología , Antiinflamatorios no Esteroideos/uso terapéutico , Glucemia/efectos de los fármacos , Péptido C/sangre , Curcumina/administración & dosificación , Curcumina/farmacología , Ácidos Ciclohexanocarboxílicos/administración & dosificación , Ácidos Ciclohexanocarboxílicos/farmacología , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/complicaciones , Neuropatías Diabéticas/sangre , Quimioterapia Combinada/métodos , Gabapentina , Gliclazida/administración & dosificación , Gliclazida/farmacología , Hiperalgesia/tratamiento farmacológico , Hipoglucemiantes/administración & dosificación , Hipoglucemiantes/farmacología , Hipoglucemiantes/uso terapéutico , Peróxidos Lipídicos/sangre , Masculino , Umbral del Dolor/efectos de los fármacos , Ácido Peroxinitroso/sangre , Ratas , Ratas Sprague-Dawley , Factor de Necrosis Tumoral alfa/sangre , Ácido gamma-Aminobutírico/administración & dosificación , Ácido gamma-Aminobutírico/farmacología
14.
BMC Complement Altern Med ; 12: 60, 2012 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-22551254

RESUMEN

BACKGROUND: Nanoparticles are small-scale substances (<100 nm) with unique properties. Therefore, nanoparticles pose complex health risk implications. The objective of this study was to detect whether treatment with quercetin (Qur) and/or arginine (Arg) ameliorated nephrotoxicity induced by two different doses of nano zinc oxide (n-ZnO) particles. METHOD: ZnO nanoparticles were administered orally in two doses (either 600 mg or 1 g/Kg body weight/day for 5 conscutive days) to Wister albino rats. In order to detect the protective effects of the studied antioxidants against n-ZnO induced nepherotoxicity, different biochemical parameters were investigated. Moreover, histopathological examination of kidney tissue was performed. RESULTS: Nano zinc oxide-induced nephrotoxicity was confirmed by the elevation in serum inflammatory markers including: tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6); and C-reactive protein (CRP). Moreover, immunoglobulin (IGg), vascular endothelium growth factor (VEGF), and nitric oxide (NO) were significantly increased in rat serum. Serum urea and creatinine levels were also significantly increased in rats intoxicated with n-ZnO particles compared with the control group. Additionally, a significant decrease in the non-enzymatic antioxidant reduced glutathione (GSH) was shown in kidney tissues and serum glucose levels were increased. These biochemical findings were supported by a histopathological examination of kidney tissues, which showed that in the animals that received a high dose of n-ZnO, numerous kidney glomeruli underwent atrophy and fragmentation. Moreover, the renal tubules showed epithelial desquamation, degeneration and necrosis. Some renal tubules showed casts in their lumina. Severe congestion was also observed in renal interstitium. These effects were dose dependent. Cotreatment of rats with Qur and/or Arg along with n-ZnO significantly improved most of the deviated tested parameters. CONCLUSIONS: The data show that Qur has a beneficial effect against n-ZnO oxidative stress and related vascular complications. Also, its combination with Arg proved to be even more effective in ameliorating nano zinc oxide nephrotoxicity.


Asunto(s)
Arginina/uso terapéutico , Mediadores de Inflamación/metabolismo , Enfermedades Renales/tratamiento farmacológico , Riñón/efectos de los fármacos , Nanopartículas/efectos adversos , Estrés Oxidativo/efectos de los fármacos , Quercetina/uso terapéutico , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Arginina/farmacología , Atrofia , Biomarcadores/sangre , Biomarcadores/metabolismo , Glucemia/metabolismo , Creatinina/sangre , Citocinas/sangre , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Epitelio/efectos de los fármacos , Epitelio/patología , Glutatión/metabolismo , Inmunoglobulina G/sangre , Riñón/metabolismo , Riñón/patología , Enfermedades Renales/etiología , Enfermedades Renales/metabolismo , Enfermedades Renales/patología , Necrosis , Óxido Nítrico/sangre , Fitoterapia , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Quercetina/farmacología , Ratas , Ratas Wistar , Fármacos Renales/farmacología , Fármacos Renales/uso terapéutico , Urea/sangre , Factor A de Crecimiento Endotelial Vascular/sangre , Óxido de Zinc
16.
Sci Rep ; 10(1): 3336, 2020 02 24.
Artículo en Inglés | MEDLINE | ID: mdl-32094406

RESUMEN

Depression is still one of challenging, and widely encountered disorders with complex etiology. The role of healthy diet and olive oil in ameliorating depression has been claimed. This study was designed to explore the effects of oleuropein; the main constituent of olive oil; on depression-like behaviors that are induced by repeated administration of corticosterone (40 mg/kg, i.p.), once a day for 21 days, in mice. Oleuropein (8, 16, and 32 mg/kg, i.p.) or fluoxetine (20 mg/kg, positive control, i.p.1) was administered 30 minutes prior to corticosterone injection. Sucrose consumption test, open-field test (OFT), tail suspension test (TST), and forced swimming test (FST) were performed. Reduced Glutathione (GSH), lipid peroxidation, and biogenic amines; serotonin, dopamine, and nor-epinephrine; levels were also analyzed in brain homogenates. Corticosterone treatment induced depression-like behaviors, it increased immobility time in the TST, OFT, and FST, decreased the number of movements in OFT, and decreased sucrose consumption. Corticosterone effect was associated with depletion of reduced glutathione and increase of lipid peroxidation, in addition to modification of biogenic amines; decreased serotonin and dopamine. Oleuropein or fluoxetine administration counteracted corticosterone-induced changes. In conclusion, oleuropein showed a promising antidepressant activity, that is evident by improving corticosterone-induced depression-like behaviors, and normalizing levels of biogenic amines.


Asunto(s)
Conducta Animal , Aminas Biogénicas/metabolismo , Depresión/inducido químicamente , Depresión/metabolismo , Iridoides/farmacología , Anhedonia/efectos de los fármacos , Animales , Conducta Animal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/patología , Corticosterona , Depresión/complicaciones , Modelos Animales de Enfermedad , Suspensión Trasera , Inmovilización , Glucósidos Iridoides , Masculino , Ratones , Movimiento , Neurotransmisores/metabolismo , Estrés Oxidativo/efectos de los fármacos , Sacarosa , Natación
17.
Naunyn Schmiedebergs Arch Pharmacol ; 393(3): 381-394, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-31641819

RESUMEN

PURPOSE: The purpose of the present study was to investigate the preventive effect of L-arginine (ARG) and carnosine (CAR) on hypoxia-induced neurotoxicity in rats. The impact on neuro-inflammation, apoptosis, angiogenesis, and the brain levels of monoamines and GABA were investigated. METHODS: Rats were divided into the following: normal control, hypoxia model induced by sodium nitrite (75 mg/kg s.c), and hypoxic rats pre-treated with CAR (250 mg/kg), ARG (200 mg/kg), and their combination. RESULTS: Data revealed that hypoxia induced significant elevation of hypoxia inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF), and its receptor reflecting the stimulation of angiogenesis. Hypoxia also resulted in increased inflammatory mediators-including nuclear factor kappa B (NF-κB), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). In addition, hypoxia initiates cerebral apoptosis as revealed by increased caspase-3 and BAX with reduced Bcl-2. These changes were associated with reduced brain levels of GABA and monoamines including noradrenaline (NADR), dopamine (DOP), and serotonin (SER). Pre-treatment with ARG and/or CAR significantly mitigated the neural changes induced by hypoxia and attenuated the elevated levels of NF-κB, TNF-α, IL-6, caspase-3, and BAX, while ameliorated the reduced levels of Bcl-2, NADR, DOP, SER, and GABA, with the best improvement observed with the combination. Further elevation of the angiogenic markers was observed indicating their role in boosting oxygen delivery to brain. CONCLUSION: CAR, ARG, and, importantly, their combination could effectively protect against hypoxia-induced neurotoxicity, via their angiogenic, anti-inflammatory, and anti-apoptotic properties in addition to reversing the effect on GABA and monoamines.


Asunto(s)
Inductores de la Angiogénesis/metabolismo , Arginina/administración & dosificación , Monoaminas Biogénicas/metabolismo , Encéfalo/metabolismo , Carnosina/administración & dosificación , Hipoxia/metabolismo , Ácido gamma-Aminobutírico/metabolismo , Animales , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Monoaminas Biogénicas/antagonistas & inhibidores , Encéfalo/efectos de los fármacos , Regulación hacia Abajo/efectos de los fármacos , Regulación hacia Abajo/fisiología , Quimioterapia Combinada , Expresión Génica , Enfermedades Hematológicas/tratamiento farmacológico , Enfermedades Hematológicas/metabolismo , Hipoxia/tratamiento farmacológico , Mediadores de Inflamación/antagonistas & inhibidores , Mediadores de Inflamación/metabolismo , Masculino , Distribución Aleatoria , Ratas , Ratas Wistar , Regulación hacia Arriba
18.
Behav Pharmacol ; 20(7): 635-42, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19745723

RESUMEN

Several studies have evaluated thiazolidinedione therapy as medical treatments for some central nervous system disorders, such as cognitive deficits associated with neurodegenerative disorders. However, there is limited data to support a direct role for peroxisome proliferator-activated receptor-γ agonists in depression. Therefore, the aim of this study was to investigate antidepressant-like activity of rosiglitazone using the mouse tail suspension test and the rat forced swimming test, two models sensitive to the effects of antidepressants. In the tail suspension test, 5 days of treatment with rosiglitazone (8.5 or 17 mg/kg, orally) reduced immobility time. In the forced swimming test, rosiglitazone (6 or 12 mg/kg, orally) treatment decreased immobility time and increased climbing. These effects were not accompanied by any alteration in locomotor activity in the open field test. Rosiglitazone treatment (6 or 12 mg/kg, orally) significantly reduced plasma corticosterone levels in rats. GW9662 significantly inhibited the rosiglitazone-induced reduction in the duration of immobility. In summary, this study suggests that rosiglitazone possesses a specific antidepressant-like activity in behavioral models and that this effect may be mediated by reduction of plasma corticosterone level.


Asunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/tratamiento farmacológico , Pérdida de Tono Postural/efectos de los fármacos , PPAR gamma/agonistas , Natación , Tiazolidinedionas/uso terapéutico , Anilidas/farmacología , Animales , Antidepresivos/farmacología , Corticosterona/sangre , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Masculino , Ratones , Actividad Motora/efectos de los fármacos , PPAR gamma/antagonistas & inhibidores , Ratas , Ratas Wistar , Rosiglitazona , Tiazolidinedionas/farmacología
19.
Dose Response ; 16(2): 1559325818776204, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29872369

RESUMEN

This study assessed the effect of L-arginine (L-argin), carnosine (carno), or their combination in the amelioration of certain biochemical indices induced in the liver of hypoxic rats. Hypoxia was induced via sodium nitrite (S.nit) injection at a dose of 75 mg/kg. Rats were administered L-argin (250 mg/kg) or carno (250 mg/kg), either alone or in combination, 24 hours and 1 hour prior to S.nit intoxication. Hypoxia significantly elevated serum alanine aminotransferase, in addition to a significant upregulation of hepatic heat shock protein 70 with concurrent reduction in the level of vascular endothelial growth factor. Moreover, hepatic vascular endothelial growth factor 1 (flt-1), hypoxia inducible factor-1α gene expression, and cytochrome P450 levels were elevated, compared with the normoxic group. The antioxidants, administered either alone or in combination, markedly downregulated all of the previously mentioned biomarkers, compared to the hypoxic rats. Histopathological examination revealed hepatocellular degeneration and nuclear pyknosis, in addition to inflammatory cellular infiltration in the hypoxic rats, whereas treatment with the studied antioxidants improved the liver architecture. The present data revealed the efficacy of L-argin and carno in ameliorating the hepatic damage induced via angiogenic markers in response to hypoxia, the combination regimen showing the superior effect.

20.
Biomed Pharmacother ; 107: 347-358, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30099338

RESUMEN

The present study aimed to investigate the protective effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on diabetic cardiomyopathy (DCM)-associated apoptosis and if this effect is mediated via modulating the activity of the survival kinases; AMP-activated protein kinase (AMPK) and Akt & the apoptotic kinases; glycogen synthase kinase-3 ß (GSK-3ß) and p38 mitogen-activated protein kinase (p38MAPK). Diabetes was induced by a single intraperitoneal injection of streptozotocin (55 mg/kg). Diabetic rats were treated with sitagliptin (10 mg/kg/day, p.o.) and metformin (200 mg/kg/day, p.o. as positive control) for six weeks. Chronic hyperglycemia resulted in elevation of serum cardiac biomarkers reflecting cardiac damage which was supported by H&E stain. The mRNA levels of collagen types I and III were augmented reflecting cardiac fibrosis and hypertrophy which was supported by Masson trichome stain and enhanced phosphorylation of p38MAPK. Cardiac protein levels of cleaved casapse-3, BAX were elevated, whereas, the levels of Bcl-2 and p-BAD were reduced indicating cardiac apoptosis which could be attributed to the diabetes-induced reduced phosphorylation of Akt and AMPK with concomitant augmented activation of GSK-3ß and p38MAPK. Protein levels of liver kinase B-1, the upstream kinase of AMPK were also supressed. Sitagliptin administration alleviated the decreased phosphorylation of AMPK and Akt, inactivated the GSK-3ß and p38 AMPK, therefore, attenuating the apoptosis and hypertrophy induced by hyperglycemia in the diabetic heart. In conclusion, sitagliptin exhibits valuable therapeutic potential in the management of DCM by attenuating apoptosis. The underlying mechanism may involve the modulating activity of AMPK, Akt, GSK-3ß and p38MAPK.


Asunto(s)
Apoptosis , Cardiomiopatías Diabéticas/enzimología , Cardiomiopatías Diabéticas/patología , Miocardio/patología , Transducción de Señal , Fosfato de Sitagliptina/farmacología , Quinasas de la Proteína-Quinasa Activada por el AMP , Proteínas Quinasas Activadas por AMP/metabolismo , Animales , Apoptosis/efectos de los fármacos , Biomarcadores/sangre , Glucemia/metabolismo , Peso Corporal/efectos de los fármacos , Colágeno/genética , Colágeno/metabolismo , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/patología , Cardiomiopatías Diabéticas/sangre , Modelos Animales de Enfermedad , Ácidos Grasos/sangre , Péptido 1 Similar al Glucagón/metabolismo , Glucógeno Sintasa Quinasa 3 beta/metabolismo , Masculino , Metformina/farmacología , Proteína Quinasa 14 Activada por Mitógenos/metabolismo , Tamaño de los Órganos/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA